Gallagher J, Russell L, McAlister M, Brockbank J. Impact of gemtuzumab ozogamicin on the Irish healthcare system. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Mokgokong R, Mamolo C, Cappelleri J, Knight C, Brockbank J, Cawson M, Dombre H, Castaigne S. Cost-effectiveness of gemtuzumab ozogamicin in combination with standard of care chemotherapy (daunorubicin and cytarabine) for first-line treatment of acute myeloid leukaemia. Poster presented at the 2019 British Society for Haematology Meeting; April 1, 2019. Glasgow, Scotland.